Venous leg ulcers
 Chadwick, P, Acton, C. The use of amelogenin protein in the treatment of hard-to-heal wounds.
British Journal of Nursing 2009; 18 (6 Suppl): S22-S29. - McCardle, J., Brewin, E., Young, M. Use of a synthetic extra-cellular matrix protein in non-healing diabetic foot wounds.
The Diabetic Foot Journal 2009; 12 (1).
- Huldt-Nystrom, T. Treatment of infected hard-to-heal venous leg ulcers with amelogenin in conjunction with topical silver dressings.
Poster presented at the 3rd Congress of the World Union of Wound Healing Societies, Toronto, Canada, 2008.
- Huldt-Nystrom, T., Meuleneire, F., Acton, C. Xelma, an advanced wound treatment for venous ulcers: a European perspective.
Wounds UK 2008; 4 (1): 106-110
- Korber, A., Dissemond, J. Behandlung bei therapierefraktaren wunden mit amelogenin: hard-to-heal - was tun?
Pflegezelschrift 2008; 61 (3): 138-40.
- Ragnarson Tennvall, G., Romanelli, M. Quality of life assessments with the EuroQol instrument (EG-5D) in a clinical trial of an advanced therapy using amelogenin in patients with chronic venous leg ulcers.
Poster presented at the 3rd Congress of the World Union of Wound Healing Societies, Toronto, Canada, 2008.
 Romanelli,M., Dini, V., Vowden, P., Agren, M.S. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence.
Clinical Interventions in Ageing 2008; 3 (2):1-10 - Romanelli, M., Kaha, E., Stege, H., Wnorowski, J.W., Vowden, P. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers: follow-up data.
Journal of Wound Care 2008; 17 (1): 17-23.
- Acton, C. The evaluation of an advanced treatment (Xelma) on hard-to-heal leg ulcers that have not responded to standard therapy.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Hampton, S., Kerr, A., Bree-Aslan, C. An evaluation of a matrix replacement treatment in intractable wounds.
Poster presentation. European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Huldt-Nystrom, T., Bonesronning, J.H., Dofour, N., et al. Treatment of hard-to-heal chronic venous ulcerations with amelogenin.
An update on the Norwegian experience. Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Meuleneire, F. A preliminary evaluation of an advanced therapy (Xelma®) for the treatment of hard to heal wounds: venous leg ulcers and diabetic foot ulcers.
Poster presented at the Symposium on Advances in Wound Care, Tampa, United States of America, 2007.
- Rippon, M., Davies, P., White, R., Bosanquet, N. The economic impact of hard-to-heal leg ulcers.
Wounds UK 2007; 3 (2): 58-69.
- Vowden, K., McGowan, J., Pilcher, M., D'Arcy, A., Renton, C., Warner, V., Megson, J., Vowden, P. Experience with the use of an amelogenin-based extracellular matrix substitute in the management of a variety of complex hard-to-heal chronic wounds.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Vowden, P., Romanelli, M., Price, P. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers.
Journal of Wound Care 2007; 16 (5): 189-95.
- Huldt-Nystrom, T. Amelogenin (Xelma) Norske erfaringer etter 9 maneders bruk.
SAR 2006; 14 (94): 183-8.
- Huldt-Nystrom, T., Bonesronning, J.H., Dofour, N., et al. Treatment of hard-to-heal chronic venous ulcerations with amelogenin.
The Norwegian experience. Poster presented at Wounds UK, Harrogate, United Kingdom, 2006.
- Romanelli M, Ellervee T, Jarve H, Kaha H. Amelogenins (Xelma®) in hard-to-heal venous leg ulcers, an open regime investigation.
Poster presented at the European Wound Management Association Conference, Prague, Czech Republic, 2006.
- Uusimaki, K., Poyry, A. Evaluation of a new extracellular matrix protein for wound treatment on a hard-to-heal venous leg ulcer: a case study evaluation.
Poster presentation at Wounds UK, Harrogate, United Kingdom, 2006.
- Vowden, P., Romanelli, M., Peter, R., Boström, Â., Josefsson, A., Stege, H. The effect of amelogenins (Xelma®) on hard-to-heal venous leg ulcers.
Wound Repair and Regeneration 2006; 14 (3): 243-6.
- Karlsmark, T., Joergensen, B., Avnstorp, C, Lykke Soerensen, J. Enamel matrix protein (EMP) in hard-to-heal venous leg ulcers, a controlled pilot study.
Poster presented at the 19th Annual Symposium on Advances in Skin and Wound Care, Phoenix, Arizona, United States of America, 2003.
- Richards, K., Chadwick, P. Case study evaluation of Xelma in the treatment of hard-to-heal diabetic foot ulcers.
Poster presented at Wounds UK Conference, Harrogate, United Kingdom, 2008.
- Romanelli,M., Dini, V., Vowden, P., Agren, M.S. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence.
Clinical Interventions in Ageing 2008; 3 (2):1-10
- Vowden, K., D'Arcy, A. Treatment of hard-to-heal diabetic and neuropathic foot ulcers with amelogenin, an extracellular matrix protein.
Poster presented at the 3rd Congress of the World Union of Wound Healing Societies, Toronto, Canada, 2008.
- Johnstone, A. Case study evaluating the effectiveness of chronic hard to heal wounds using Xelma (extracellular matrix protein).
Poster presented at Wounds UK, Harrogate, United Kingdom, 2007.
- Meuleneire, F. A preliminary evaluation of an advanced therapy (Xelma®) for the treatment of hard to heal wounds: venous leg ulcers and diabetic foot ulcers.
Poster presented at the Symposium on Advances in Wound Care, Tampa, United States of America, 2007.
- Chadwick, P, Acton, C. The use of amelogenin protein in the treatment of hard-to-heal wounds.
British Journal of Nursing 2009; 18 (6 Suppl): S22-S29.
- Romanelli,M., Dini, V., Vowden, P., Agren, M.S. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence.
Clinical Interventions in Ageing 2008; 3 (2):1-10
- Bertone, M.S., Barbanera, S., Brilli, C., et al. The use of amelogenin in pyoderma gangrenosum.
Poster presentation at the European Wound Management Association conference, Glasgow, United Kingdom, 2007.
- Chadwick, P, Acton, C. The use of amelogenin protein in the treatment of hard-to-heal wounds.
British Journal of Nursing 2009; 18 (6 Suppl): S22-S29.
- Vowden, K., D'Arcy, A. Treatment of hard-to-heal diabetic and neuropathic foot ulcers with amelogenin, an extracellular matrix protein.
Poster presented at the 3rd Congress of the World Union of Wound Healing Societies, Toronto, Canada, 2008.
- Vowden, K., McGowan, J., Pilcher, M., D'Arcy, A., Renton, C., Warner, V., Megson, J., Vowden, P. Experience with the use of an amelogenin-based extracellular matrix substitute in the management of a variety of complex hard-to-heal chronic wounds.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Chadwick, P, Acton, C. The use of amelogenin protein in the treatment of hard-to-heal wounds.
British Journal of Nursing 2009; 18 (6 Suppl): S22-S29.
- Vowden, K., McGowan, J., Pilcher, M., D'Arcy, A., Renton, C., Warner, V., Megson, J., Vowden, P. Experience with the use of an amelogenin-based extracellular matrix substitute in the management of a variety of complex hard-to-heal chronic wounds.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Chadwick, P, Acton, C. The use of amelogenin protein in the treatment of hard-to-heal wounds.
British Journal of Nursing 2009; 18 (6 Suppl): S22-S29.
- Vowden, K., McGowan, J., Pilcher, M., D'Arcy, A., Renton, C., Warner, V., Megson, J., Vowden, P. Experience with the use of an amelogenin-based extracellular matrix substitute in the management of a variety of complex hard-to-heal chronic wounds.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007.
- Vowden, K., McGowan, J., Pilcher, M., D'Arcy, A., Renton, C., Warner, V., Megson, J., Vowden, P. Experience with the use of an amelogenin-based extracellular matrix substitute in the management of a variety of complex hard-to-heal chronic wounds.
Poster presented at the European Wound Management Association Conference, Glasgow, United Kingdom, 2007. |